Investor Relations
Vitro Diagnostics dba Vitro Biopharma develops and commercialize adult stem cell technology for applications in stem cell research, drug development and therapeutic products for treatment a vast variety of diseases and conditions. We offer a series of tools to promote the development of stem cell research and clinical applications focusing on Mesenchymal Stem Cells (MSCs).
Become an Investor: Call (303) 999-2137
Vitro Diagnostics, Inc. (OTCPK:VODG)
Company Information
Vitro Biopharma
4621 Technology Drive
Golden, CO 80403
303-999-2130
www.vitrobiopharma.com
Investor Relations
John Evans
CFO & Director
john@vitrobiopharma.com
(303) 999-2137
wwww.vitrobiopharma.com
Transfer Agent
Securities Transfer Corporation
2591 Dallas Parkway, Suite 102
Frisco, TX 75034
469-633-0100
www.stctransfer.com
Share Statistics
Outstanding: 46,194,200
(As of June 26th, 2018)
Press Releases
Vitro Biopharma 3rd Quarter ended July 31st 2019 Financial Results of Operations
Vitro Biopharma 3rd Quarter ended July 31st 2019 Financial Results of Operations Golden, Colorado-September 25th, 2019-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 3rd quarter ended September 24th 2019 financial results of operations....
Vitro Biopharma 2nd Quarter ended April 30th 2019 Financial Results of Operations
Golden, Colorado-June 19th, 2019-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 2nd quarter ended April 30th 2019 financial results of operations. Vitro Diagnostics Inc. (“Vitro Biopharma”) is pleased to announce a record 2nd quarter in Stem...
Vitro Biopharma Receives ISO 13485 Certification Supporting its Stem Cell Medical Tourism Initiative
Golden, Colorado-April 30, 2019-Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma one of the world’s emerging biotechnology companies focused on allogeneic Mesenchymal Stem Cell (“MSC”) research and clinical products including AlloRx Stem Cells™, Brain Grow...
Vitro Biopharma Obtains CLIA Certification
Golden, Colorado—April 2, 2019—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma announced receipt of a Certificate of Compliance with CLIA (Clinical Laboratory Improvement Amendment) without deficiencies. This allows Vitro Biopharma to perform clinical...
Vitro Biopharma 1st Quarter ended January 31st 2019 Financial Results of Operations
Golden, Colorado-March 21, 2018-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 1st quarter ended January 31st 2019 financial results of operations. Vitro Diagnostics Inc. (“Vitro Biopharma”) is pleased to announce a record 1st quarter in...
Vitro Biopharma Receives Approval for a Stem Cell Clinical Trial for Musculoskeletal Conditions by the Bahamas Ministry of Health
Golden, Colorado—March 12, 2019—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma announced receipt of provisional approval from the National Stem Cell Ethics Committee (NSCEC) of the Ministry of Health of the Commonwealth of the Bahamas for a clinical trial...
Vitro Biopharma 2018 CEO Shareholder Letter
Press Release Source: Vitro Diagnostics, Inc. Vitro Biopharma 2018 CEO Shareholder Letter:Record Revenues from Stem Cell Treatments Lead to 4th Quarter BreakevenCashflow & Growth...
Vitro Biopharma Receives ISO 9001 Certification of its Quality Management System
Golden, Colorado-December 12th, 2018-Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma (“Vitro”) one of the world’s emerging biotechnology companies focused on Umbilical Cord Mesenchymal Stem Cell (“MSC”) research and clinical products has been awarded...
Vitro BioPharma Engages Senior Director of Sales and Marketing
Vitro BioPharma engages Senior Director of Sales and Marketing GOLDEN, CO/ACCESSWIRE/October 23,2018/Vitro Diagnostics, Inc. (OTC PINK: VODG), dba Vitro BioPharma today announced the engagement of a senior Sales and Marketing Director. The company has engaged Keith V....
Vitro Biopharma 3rd Quarter Ended July 31st 2018 Financial Results of Operations.
Vitro Biopharma 3rd Quarter 2018 Financial Results of Operations Golden, Colorado-September 24th, 2018-Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro BioPharma, announced its 3rd quarter financial results of operations, ended July 31st, 2018. Vitro Diagnostics Inc....
Providing high quality commercialized cell lines, media, stem cell products & stem cell technology
Providing applications in stem cell research, drug discovery and STEM CELL therapies
Customer Service (303)-999-2130 Ext. 1
4621 Technology Drive Golden, CO 80403
Technical Support (303)-999-2130 Ext. 2
info@vitrobiopharma.com
Accounting (303)-999-2130 Ext. 3
Please click the image above to view our ISO 13485:2016.
Please click the image above to view our ISO 9001:2015 Certification.
Please click the image above to view our FDA registration.